CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,502,519 | -11.7% | 51,002 | -2.2% | 0.01% | 0.0% |
| Q2 2023 | $1,701,949 | -5.1% | 52,175 | +2.4% | 0.01% | -13.3% |
| Q1 2023 | $1,793,141 | -33.3% | 50,956 | -13.2% | 0.02% | -37.5% |
| Q4 2022 | $2,690,183 | +54.0% | 58,712 | +62.9% | 0.02% | +50.0% |
| Q3 2022 | $1,747,000 | +697.7% | 36,042 | +283.0% | 0.02% | +1500.0% |
| Q1 2021 | $219,000 | -43.8% | 9,410 | -49.9% | 0.00% | -50.0% |
| Q4 2020 | $390,000 | -78.2% | 18,775 | -84.8% | 0.00% | -50.0% |
| Q3 2017 | $1,790,000 | +30.7% | 123,456 | +9.0% | 0.00% | 0.0% |
| Q2 2017 | $1,370,000 | +1531.0% | 113,255 | +543.2% | 0.00% | – |
| Q2 2014 | $84,000 | -50.6% | 17,607 | -1.6% | 0.00% | – |
| Q1 2014 | $170,000 | +107.3% | 17,897 | +41.6% | 0.00% | – |
| Q4 2013 | $82,000 | -1.2% | 12,635 | +15.5% | 0.00% | – |
| Q3 2013 | $83,000 | – | 10,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |